Phageolytix, Inc.
Phageolytix develops bacteriophage-based solutions to address antimicrobial resistance. Activities described on the site include isolation, identification and purification of bacteriophages, genomic sequencing and analysis, discovery and formulation of phage cocktails for wound and respiratory infections, development of phage-infused dressings, and technology licensing.
Industries
N/A
Products
Phage cocktails for wound infections
Combined bacteriophage formulations intended to target bacterial pathogens in wound infections.
Phage cocktails for respiratory infections
Phage combinations aimed at respiratory pathogens implicated in bronchiectasis, cystic fibrosis, and hospital-acquired infections.
Phage-infused dressings
Topical dressing products formulated to deliver bacteriophages to wound sites.
Phage cocktails for wound infections
Combined bacteriophage formulations intended to target bacterial pathogens in wound infections.
Phage cocktails for respiratory infections
Phage combinations aimed at respiratory pathogens implicated in bronchiectasis, cystic fibrosis, and hospital-acquired infections.
Phage-infused dressings
Topical dressing products formulated to deliver bacteriophages to wound sites.
Services
Phage discovery and cocktail development
Identification and combination of bacteriophages into cocktails targeted to specific bacterial pathogens for wound and respiratory indications.
Phage-infused dressing formulation
Formulation of bacteriophage-containing dressings or topical products intended for wound infection management.
Genomic sequencing and analysis of bacteriophages
Sequencing and characterization of phage genomes to support discovery, safety assessment, and documentation.
Technology licensing and partnership support
Management of licensing arrangements and external partnerships for technology transfer and commercialization of phage technologies.
Phage discovery and cocktail development
Identification and combination of bacteriophages into cocktails targeted to specific bacterial pathogens for wound and respiratory indications.
Phage-infused dressing formulation
Formulation of bacteriophage-containing dressings or topical products intended for wound infection management.
Genomic sequencing and analysis of bacteriophages
Sequencing and characterization of phage genomes to support discovery, safety assessment, and documentation.
Technology licensing and partnership support
Management of licensing arrangements and external partnerships for technology transfer and commercialization of phage technologies.
Expertise Areas
- Phage therapy research
- Antimicrobial resistance solutions
- Bacteriophage genomics
- Wound-care therapeutics
Key Technologies
- Bacteriophage isolation and purification
- Phage cocktail formulation
- Phage-infused dressing formulation
- Whole genome sequencing of phages